Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension

被引：0
|
作者：
White, R. J. [1 ]
Chakinala, M. [2 ]
Rischard, F. [3 ]
Howell, M. [4 ]
Laliberte, K. [4 ]
Feldman, J. [5 ]
机构：
[1] Univ Rochester, Rochester, NY USA
[2] Washington Univ, St Louis, MO USA
[3] Univ Arizona, Tucson, AZ USA
[4] United Therapeut Corp, Res Triangle Pk, NC USA
[5] Arizona Pulm Specialists, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2460
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety And Tolerability Of Transitioning From Parenteral Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    White, R. J.
    Chakinala, M. M.
    Mathier, M.
    Howell, M.
    Laliberte, K.
    Feldman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [2] Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    Khan, A. A.
    Ackerbauer, K.
    Tandon, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    [J]. PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [4] Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension
    Preston, Ioana R.
    Feldman, Jeremy
    White, James
    Franco, Veronica
    Ishizawar, David
    Burger, Charles
    Waxman, Aaron B.
    Hill, Nicholas S.
    [J]. PULMONARY CIRCULATION, 2014, 4 (03) : 456 - 461
  • [5] Transition from parenteral to oral treprostinil in pulmonary arterial hypertension
    Chakinala, Murali M.
    Feldman, Jeremy P.
    Rischard, Franz
    Mathier, Michael
    Broderick, Meredith
    Leedom, Nicole
    Laliberte, Kevin
    White, R. James
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (02): : 193 - 201
  • [6] Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry
    Lachant, D.
    Minkin, R.
    Swisher, J.
    Mogri, M.
    Zolty, R.
    Hwang, S.
    Seaman, S.
    Broderick, M.
    Sahay, S.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [7] Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
    Arevalo, Carlo
    White, R. James
    Lachant, Daniel
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2022, 37
  • [8] Transition to Oral Treprostinil from Parenteral or Inhaled Treprostinil or as Add-On Therapy in Pediatric Subjects with Pulmonary Arterial Hypertension
    Ivy, D.
    Feinstein, J.
    Yung, D.
    Mullen, M.
    Kirkpatrick, E.
    Hirsch, R.
    Austin, E. D.
    Fineman, J.
    Doran, A.
    Solum, D.
    Deng, C.
    Hopper, R. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Uptitration of Pulmonary Arterial Hypertension Therapies: Transition From Oral Selexipag to Parenteral Treprostinil
    Krishnan, M.
    Gomberg-Maitland, M.
    Dias-Douglas, J. M.
    Sherner, J.
    Choi, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S560 - S560
  • [10] Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension
    Vachiéry, JL
    Hill, N
    Zwicke, D
    Barst, R
    Blackburn, S
    Naeije, R
    [J]. CHEST, 2002, 121 (05) : 1561 - 1565
12345